Abstract:Objective To investigate the effectiveness and safety of endoscopic mucosal resection with precutting (EMR-P) for the treatment of rectal neuroendocrine neoplasm (RNEN) smaller than 1 cm in diameter.Methods Clinical data of 177 patients with RNEN smaller than 1 cm in diameter from December 2016 to December 2021 were retrospectively analyzed. According to different treatment protocols, 177 patients with RNEN were divided into endoscopic mucosal resection (EMR) group (n = 46), EMR-P group (n = 40) and endoscopic submucosal dissection (ESD) group (n = 91). The en bloc resection rate, complete resection rate, operation time, postoperative hospitalization time and incidence of operative complications among the three groups were compared.Results The complete resection rate in the EMR-P group (95.0%) and ESD group (97.8%) were significantly higher than that in the EMR group (87.0%) (P < 0.05); The operation time in the EMR-P group (9.86 ± 2.23) min was longer than that in the EMR group (4.12 ± 0.88) min, EMR-P group and EMR group were shorter than that in the ESD group (19.55 ± 3.67) min, the difference was statistically significant (P < 0.05); Postoperative hospitalization time in the EMR group was (2.45 ± 0.29) d and EMR-P group was (2.43 ± 0.23) d, which were shorter than that in the ESD group (3.30 ± 0.32) d, and the difference was statistically significant (P < 0.05). There were no significant difference in the rates of en bloc resection and operative complications among the three groups (P > 0.05).Conclusion EMR-P for the treatment of RNEN < 1 cm in diameter has the advantages, such as simple operation, short operation time and hospitalization time, high histological complete resection rate and low complication rate, which is worthy of clinical application.